Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by IndividualfiledCriticalIndividual
Priority to ES8902810ApriorityCriticalpatent/ES2015772A6/en
Publication of ES2015772A6publicationCriticalpatent/ES2015772A6/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
Process for obtaining new 5-fluorouracil derivatives, specifically N1-acyl-substituted-N3-orthotoluyl-5- fluorouracil (STF), of application in human medicine as anti-cancer agents. Essentially the process comprises adding an anhydride or chloride selected from the group of acids comprising acetic, glycolic, methoxy acetic, amino acetic and thioglycolic acids to a solution of N3- orthotoluyl-5-FU.
ES8902810A1989-08-071989-08-07Process for obtaining new 5-fluorouracil derivatives, specifically N1-acyl-substituted-N3-orthotoluyl-5- fluorouracil
Expired - LifetimeES2015772A6
(en)
3-Demethyl-4-fluoro-mevalonic-acid derivatives process for their preparation pharmaceutical preparations based on those compounds their use and intermediates
New 6-fluoro-3,5-dihydroxy carboxylic acids and derivatives thereof,a process for the preparation thereof,the use thereof as medicinal agents,pharmaceutical products and intermediates
Protein c inhibitor (pci) as pharmaceutical and in vitro diagnostic aid, a process for the preparation of a pharmaceutical or diagnostic aid of this type, and an agent containing pci